Health Care/Hospital

NEW THERAPY FOR RARE GASTROINTESTINAL STROMAL TUMOURS APPROVED IN SINGAPORE

* Singapore's Health Sciences Authority (HSA) has approved QINLOCK® (ripretinib) for the treatment of patients with 4th line GIST * QINLOCK significantly reduced the risk of disease progression or death by 85% and showed clinically meaningful overall survival in theINVICTUS Phase 3 Study1,2 ...

2023-05-08 04:00 2011

Suzhou GenAssist Therapeutic Co.,Ltd recently announced that its first base editing product, GEN6050, has submitted a pre-IND application to the FDA and has been accepted

SUZHOU, China, May 6, 2023 /PRNewswire/ -- Suzhou GenAssist Therapeutic Co.,Ltd recently announced its pre-IND application of their first base editing product, GEN6050 and the acceptance by the FDA.   GEN6050 is an in vivo base editing drug that targets exon 50 skipping in the Duchenne muscular...

2023-05-06 21:00 4772

Empowering Innovation to the Global Market with Acro Certify

NEWARK, Del., May 5, 2023 /PRNewswire/ -- For many companies, entering the global market is a daunting challenge. These obstacles can come in various forms. Sometimes the problem is finding the right target customer base or establishing an appropriate quality management system and shipping logist...

2023-05-06 10:18 4928

Vice President of Tencent HealthCare Zhang Yu: Create the "flywheel" of software development effectiveness and efficiency to drive continuous innovation in healthcare

BEIJING, May 5, 2023 /PRNewswire/ -- The digital era has ushered rapid changes in software development philosophy and process, as well as technologies and tools. For healthcare, the digital transformation of the industry allows for rapid response to major public health emergencies, stable operati...

2023-05-05 21:10 2545

CARsgen's CLDN18.2 mAb AB011 Achieves IND Clearance from the NMPA for the First-line Combination Treatment of Gastric Cancer

SHANGHAI, May 5, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announced that AB011 in combination with atezolizumab monoclonal antibody, Roche'...

2023-05-05 20:50 3378

Health In Tech Revolutionizes Level-Funded Health Plans in Ohio through Partnership with Ohio PPO Connect

STUART, Fla., May 5, 2023 /PRNewswire/ -- Health in Tech, the industry-leading insurtech company that delivers disruptive innovation and reimagines self-funded health plans, proudly announces its accelerated implementation with Ohio PPO Connect, LLC. This strategic partnership aims to provide a ...

2023-05-05 20:30 2469

ProQure and Identiv Partner to Launch Innovative NFC Type 2 Tags for Large-Scale NFC Deployments

The partnership's new PQ201/201s series tags deliver premium features at a competitive price point PLEASANTON, Calif., May 5, 2023 /PRNewswire/ -- ProQure, a technology provider of IoT cloud management for physical objects, and Identiv, a global leader in physical security and secure identificat...

2023-05-05 18:00 2511

Arbele celebrates its 7th anniversary as a clinical-stage immunotherapy biotech and the opening of TibTech, its cancer diagnostics subsidiary

SEATTLE, May 5, 2023 /PRNewswire/ -- Arbele, a biotechnology company dedicated to fighting gastrointestinal cancers, celebrates its 7th anniversary and the opening of Tiberias Technology (TibTech), its accredited lab for cancer screening and in vitro diagnostics, at the Hong Kong Science and Tech...

2023-05-05 15:00 1825

Formosa Pharmaceuticals and AimMax Therapeutics Announce the NDA Submission to the US FDA for APP13007 for the Treatment of Post-Operative Inflammation and Pain following Ocular Surgery

TAIPEI, May 4, 2023 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. (6838.TWO) and AimMax Therapeutics, Inc. (United States) announce the submission of a New Drug Application to the United States Food & Drug Administration (US FDA) for APP13007, a novel aqueous nanosuspension formulation of the pot...

2023-05-05 08:00 2001

Recall Notice - SD Biosensor, Inc. requests discontinuation of use and disposal of specific Pilot™ COVID-19 At-Home Tests in the United States due to microbial contamination in the liquid buffer solution

SEOUL, South Korea, May 4, 2023 /PRNewswire/ -- SD Biosensor, Inc. today is requesting that consumers stop using and dispose of specific Pilot COVID-19 At-Home Tests inthe United States because potentially harmful bacteria were found in the tube with liquid inside (pouch 2 of the kits). The affe...

2023-05-05 04:00 2226

ABM Announces First Patient Dosed in Phase I Clinical Trial of MEK Inhibitor for Solid Tumor

SAN DIEGO and SHANGHAI, May 4, 2023 /PRNewswire/ -- ABM Therapeutics, an innovative clinical-stage biopharmaceutical company, with an emphasis on developing drugs with high blood–brain barrier (BBB) penetration for CNS diseases including brain metastases, today announced that the first patient wa...

2023-05-05 01:00 2542

DetectedX's Radiology Online Learning Centre Passes 4,500 Users

DetectedX will Showcase New Interactive Educational Technology at SBI NATIONAL HARBOR, Md., May 4, 2023 /PRNewswire/ -- DetectedX, the leaders in intelligent interactive educational technology, announced today that it has surpassed 4,500 users of its Radiology Online Learning Centre. Users, whic...

2023-05-04 23:25 2272

Momcozy Mother's Day Deal: Choose America's Top-selling Wearable Breast Pump Chosen by 2 Million Moms

NEW YORK, May 4, 2023 /PRNewswire/ -- Momcozy, the #1 selling wearable breast pump brand inNorth America, has announced a series of irresistible deals in celebration of Mother's Day. SinceMay 4th , whether on Momcozy's website , Amazon

2023-05-04 14:59 1993

Hasten Biopharma Acquires Commercial Rights in China for Roche's Antibiotic Rocephin®

The acquisition will deliver strong commercial synergy with Hasten's current critical care portfolio SHANGHAI, May 4, 2023 /PRNewswire/ -- Hasten Biopharmaceutic Co., Ltd (China) ("Hasten") today announced that it has acquired the commercial rights inChina for Rocephin®, a long-acting, broad spe...

2023-05-04 14:00 2129

Full-Life Technologies Announces Land Purchase in Belgium to Establish GMP Manufacturing Facility for Radiopharmaceutical Drug Production

GEMBLOUX, Belgium, May 3, 2023 /PRNewswire/ -- Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today is pleased to announce that it has closed on an important land purchase in Wallonia,Belgium, and signed a purchase agreement to build a state-of-the-art, ...

2023-05-04 10:00 1891

EDAN Announces Integration with PointClickCare for Better Senior Primary Care

SAN DIEGO, May 3, 2023 /PRNewswire/ -- Edan Instruments, Inc. (300206.SZ), a leading healthcare company and medical devices manufacturer, recently announced its integration with PointClickCare through its newly launched informatics solutions Allink. The solution ...

2023-05-03 21:56 2726

Skyline Therapeutics to Present at the ASGCT 26th Annual Meeting

SHANGHAI, May 3, 2023 /PRNewswire/ -- Skyline Therapeutics, an innovation-driven gene therapy company dedicated to developing unique and novel solutions to address unmet needs in rare and severe diseases, today announced multiple data presentations at the American Society of Gene and Cell Therapy...

2023-05-03 12:00 1976

China Jo-Jo Drugstores Receives Hangzhou Municipal People's Government Quality Management Excellence Award

HANGZHOU, China, May 2, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced that the Co...

2023-05-02 20:30 3316

Mintal Tracker Honored as Bronze Stevie® Award Winner in 2023 American Business Awards®

Mintal Tracker was recognized for providing users with an easy way to achieve healthier sleep SAN FRANCISCO, May 1, 2023 /PRNewswire/ -- Mintal Tracker, a sleep tracking app driven by artificial intelligence (AI) technology that offers a scientific approach to healthier sleep, was named the winn...

2023-05-01 23:00 1649

Health Canal Survey: Why Older Adults are Hesitant to Receive the Bivalent Booster Shot

New survey by Health Canal reveals that personal health and safety concerns drive older adults' intentions and attitudes toward bivalent booster shots GROVE CITY, Ohio, May 1, 2023 /PRNewswire/ -- The CDC has recommended the bivalent mRNA COVID-19 vaccines sinceSep...

2023-05-01 22:00 1973
1 ... 99100101102103104105 ... 277

Week's Top Stories